MEDDEV 2.7/1 rev 4 - Clinical Performance & Clinical Safety Claims

FoGia

Involved In Discussions
#1
Hi there,

I've pondering the MEDDEV 2.7/1 rev 4 on clinical evaluation for quite some time now but the concepts of clinical performance & clinical safety claims still elude me.
The guideline points to the definitions of clinical performance (from ISO 14155) and clinical safety (from MEDDEV 2.7/2) without providing clear examples as to when a claim can be considered a performance or safety claim. It's especially confusing since the two concepts are used together throughout the guideline. I can't find on the web, on the site of IMDRF or other references to these concepts. What am I missing?

An example: are biocompatibility/sterilizability/compatibility performance or safety claims? Following the definitions I'd say those are performance claims (the device performs as intended). They're however not part of the intended use and I'm tempted to classify them as clinical safety claims since they're not serving the primary performance intended by the manufacturer.

But from the defintion standpoint, clinical safety claims aren't "freedom from unacceptable risks" just another way to describe the indications for use?

Could you help me articulate these notions?

Thanks
 
Elsmar Forum Sponsor

shimonv

Trusted Information Resource
#2
Hi Fogia,
Here is how I understand it although clinical affairs is not my strong suit:

Clinical Performance: Behavior of a medical device or response of the subject(s) to that medical device in relation to its intended use, when correctly applied to appropriate subject(s).

Clinical Safety: Freedom from unacceptable clinical risks, when using the device according to the manufacturer’s Instructions for Use.

In practical terms, I would say that clinical safety is evidence for risk mitigation, i.e. that you are not 'achieving' unintended, unacceptable results. For example, biocompatibility, sterilization and electrical safety.
Clinical performance is evidence that the device is archiving its intended use. For example, bench testing and clinical outcome results.

Hope it helps.

-Shimon
 
Last edited:

FoGia

Involved In Discussions
#3
Thanks for your reply Shimon!

This makes sense although for some claims this is a thin rope to walk on.
Regulators must be aware of this since they keep on rewording the definitions:
Clinical performance:
Meddev 2.7/1 rev 3:
The ability of a medical device to achieve its intended purpose as
claimed by the manufacturer.
Meddev 2.7/1 rev 4:
Behavior of a medical device or response of the subject(s) to that medical device in relation to its intended use, when correctly applied to appropriate subject(s).
MDR:
'clinical performance' means the ability of a device, resulting from any direct or indirect medical effects which stem from its technical or functional characteristics, including diagnostic characteristics, to achieve its intended purpose as claimed by the manufacturer, thereby leading to a clinical benefit for patients, when used as intended by the manufacturer;
It seems that the definitions evolve toward a more medical perspective, there needs to be a link with clinical benefits. Does that imply that performance claims must be linked to clinical benefits(this can be challenging to demonstrate for devices that have clear indications for use but represent only a part of the treatment. The MEDDEV 2.7/1 rev 4 stressess that out as well and goes on even further on page 47 about Conformity assessment with requirement on performance:
Clinical performance incudes any claims about clinical properties and safety of the device that the manufacturer intends to use.
From that I understand that clinical safety claims are part of the clinical performance claims.

I'll probably stick to your interpretation althoug I must admit some degree of confusion wtill remains.
 

shimonv

Trusted Information Resource
#4
I'll probably stick to your interpretation although I must admit some degree of confusion will remains.
What can I say... sometimes we overwork ourselves in trying to separate different yet overlapping terms.

It always comes down to safety and effectiveness. Safety is the evidence that you are not achieving undesired results and effectiveness is the evidence that are achieving the desired results. And yes, sometimes they overlap. And yes, performance is the bigger deal because in the end you need to show that the benefit is greater than to risk, and there is always a risk.

Cheers,
Shimon
 
Thread starter Similar threads Forum Replies Date
TheMightyWife Clinical Evaluation MEDDEV 2.7.1 Rev 4 demonstration of equivalence EU Medical Device Regulations 6
C Qualification of Evaluator - Clinical Evaluation Report MEDDEV 2.7.1 Rev 04 CE Marking (Conformité Européene) / CB Scheme 3
Q Sample of the MEDDEV 2.7.1 rev 4 Clinical Evaluation Report wanted Document Control Systems, Procedures, Forms and Templates 15
R Qualification of Evaluator - Clinical Evaluation Report MEDDEV 2.7.1 Rev 04 Other Medical Device and Orthopedic Related Topics 1
R Clinical Evaluation according to MEDDEV 2.7.1 (Rev 4) - seeking template ISO 13485:2016 - Medical Device Quality Management Systems 6
bio_subbu Clinical Evaluation - MEDDEV 2.7.1 Rev. 3 Released - December 2009 EU Medical Device Regulations 0
F MEDDEV 2.7/1 rev 4 and MDR - Definition of Description of Principles of operation EU Medical Device Regulations 4
E Can we still use MEDDEV 2.4/1 rev. 9 when classifying a medical device product under MDR? EU Medical Device Regulations 4
L I'm looking for Translation Procedure Guide MEDDEV 2.5/5 Rev.2 (NOT Rev.3) CE Marking (Conformité Européene) / CB Scheme 0
dgrainger Informational Additional Guidance Regarding the Vigilance System as outlined in MEDDEV 2.12-1 rev. 8 EU Medical Device Regulations 1
M CEP requirements in MEDDEV 2.7/1, rev 4 and MDR - Are all MEDDEV requirements still applicable? EU Medical Device Regulations 7
K MEDDEV 2.4/1 rev. 9 Classification EU Medical Device Regulations 1
J CER - Literature search strategy and PMV data Timeline - MEDDEV 2.7.1/ Rev 4 CE Marking (Conformité Européene) / CB Scheme 2
S Gap Analysis MDR req/MEDDEV 2.7.1 rev 4 EU Medical Device Regulations 3
H CER - Equivalent Medical Devices Criteria - MDR/MEDDEV REV 4 CE Marking (Conformité Européene) / CB Scheme 9
K MEDDEV 2.7/1 Rev 4 Appendix - A11 - Declarations of Interests EU Medical Device Regulations 2
E Gap Analysis between MEDDEV 2.7/1 rev.4 vs. rev.3 wanted EU Medical Device Regulations 3
M MEDDEV 2.7/1 rev.4 published - June 2016 EU Medical Device Regulations 42
S Revised MEDDEV 2.12-1 rev 8 Vigilance System - Released EU Medical Device Regulations 3
M MEDDEV 2.12.1 rev 6 Trending of Non-Reportable Events question ISO 13485:2016 - Medical Device Quality Management Systems 4
bio_subbu European Medical Devices Classification ?MEDDEV 2. 4/1 Rev. 9 June 2010? ISO 13485:2016 - Medical Device Quality Management Systems 5
T Vigilance System MEDDEV 2009 changes - MEDDEV 2.12-1 rev 6 for Vigilance System EU Medical Device Regulations 1
A Contradictions in the reporting timelines of IVD Directive and MEDDEV 2.12-1 Rev 5 ISO 13485:2016 - Medical Device Quality Management Systems 2
J EU Vigilance (updated MEDDEV rev.5) - Internal Forms EU Medical Device Regulations 12
Z MEDDEV 2.12-1 Rev 5 Reportability Decision Tree? Vigilance Reporting Procedure EU Medical Device Regulations 18
Gert Sorensen MEDDEV 2.12-1 rev. 5 released ISO 13485:2016 - Medical Device Quality Management Systems 0
T The “use-by“ time limit - Terminology discrepancy - MEDDEV & HS EU Medical Device Regulations 0
K Measuring Function MEDDEV 2.1/5 relation with MDD 93/42/EEC CE Marking (Conformité Européene) / CB Scheme 1
Y When will Notified Bodies require MedDev manufacturers to fully implement ISO 14971:2019? ISO 14971 - Medical Device Risk Management 1
pashah Looking for Clinical Evaluation SOP acc. MEDDEV and EU MDR Other Medical Device Related Standards 1
J MEDDEV 2.12/1's new MIR & IMDRF terms & codes (IMDRF Annex) EU Medical Device Regulations 1
Ronen E Informational The future of MEDDEV 2.7/1 EU Medical Device Regulations 4
R Clinical evaluation Meddev (2.7.1 revision 4) - Example or Template EU Medical Device Regulations 4
M Clinical Evaluation - MEDDEV 2.7/1 rev4 - Literature route Other Medical Device Related Standards 2
T MEDDEV 2.7/1 r4 vs. IMDRF/SaMD WG/N41 Other Medical Device Related Standards 3
P Label Translations - Translation procedure to meet the requirements of MEDDEV 2.5/5 ISO 13485:2016 - Medical Device Quality Management Systems 4
Sam Lazzara Clinical Evaluation MEDDEV Guidelines SmackDown - 2017 EU Medical Device Regulations 3
E CER (Clinical Evaluation Report) MEDDEV Version 4 Template wanted CE Marking (Conformité Européene) / CB Scheme 5
R Non-Conformity Report from Notified Body - MEDDEV Guide is not Legally Binding EU Medical Device Regulations 16
J Where to get meddev FSCA (Field Safety Corrective Actions) trainings EU Medical Device Regulations 7
Y Transition Period for MEDDEV 2.7.1 EU Medical Device Regulations 8
C MEDDEV equivalent requirement to CFR 806.20 EU Medical Device Regulations 2
J Good training or seminars to attend for MEDDEV 2.12-1 recommendations wanted EU Medical Device Regulations 3
SteveK NB-MED, NBOG, IMDRF and MEDDEV hierarchy EU Medical Device Regulations 3
M Australian Meddev Regulations Updated 5 Nov 2014 Other Medical Device Regulations World-Wide 0
B Inquiry about MEDDEV 2.12/2 rev2 - PMCF studies EU Medical Device Regulations 3
D Vigilance Trend reporting requirements of Meddev 2.12/ver 7 in the EU Document Control Systems, Procedures, Forms and Templates 1
N MEDDEV guideline on Post Market Surveillance (PMS) EU Medical Device Regulations 8
bio_subbu EU publishes revised guidance on Medical Devices Vigilance system MEDDEV 2.12-1 Rev7 EU Medical Device Regulations 8
bio_subbu EU publishes several new & Revised MEDDEV guidance documents (FEB 2012) EU Medical Device Regulations 0

Similar threads

Top Bottom